PreprintAll rights reservedbioRxiv
Discovery of a brain-penetrant CHI3L1 inhibitor as an oral modulator of neuroinflammation in Alzheimers disease
- 1Columbia University Irving Medical Center
Related
- Blood-brain barrier-penetrant pharmacological strategies for neuroinflammation in Alzheimer’s disease: small molecules and engineered peptides
- A First-in-Class, Brain-Penetrant Small Molecule Inhibitor of the NOS1AP-Tau Interaction Rescues Tau Pathology In Vivo and Improves Cognition
- Laromestrocel preserves brain volume and cognitive function in Alzheimers disease by inhibiting neuroinflammation
- Discovery of GluA3 preferring AMPA receptor positive allosteric modulator BRD3290
- Non-electrophilic TRPA1 modulator MNP-021 protects neuronal and glial function from diabetes-associated glucotoxicity and neuroinflammation.
BibTeX
@misc{upadhyay2026discovery,
title = {{Discovery of a brain-penetrant CHI3L1 inhibitor as an oral modulator of neuroinflammation in Alzheimers disease}},
author = {S. Upadhyay and L. Zhang and B. Kaur and L. Calvo-Barreiro and M. Teplova and M. Gabr},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.15.759511},
url = {https://www.biorxiv.org/content/10.64898/2026.10.15.759511v1},
}
RIS
TY - UNPB
TI - Discovery of a brain-penetrant CHI3L1 inhibitor as an oral modulator of neuroinflammation in Alzheimers disease
AU - S. Upadhyay
AU - L. Zhang
AU - B. Kaur
AU - L. Calvo-Barreiro
AU - M. Teplova
AU - M. Gabr
PY - 2026
DA - 2026/10/15
PB - bioRxiv
DO - 10.64898/2026.10.15.759511
UR - https://www.biorxiv.org/content/10.64898/2026.10.15.759511v1
ER -